Many households do not have enough money to pay cost-sharing typical in private health plans March 10, 2022 Issue Brief This analysis assesses whether people can afford to pay cost-sharing amounts common with private insurance plans. It finds that large shares of non-elderly households do not have enough liquid assets to meet typical plan cost-sharing amounts.
Outpatient telehealth use soared early in the COVID-19 pandemic but has since receded February 10, 2022 Issue Brief Telehealth use skyrocketed during the early months of the pandemic. While it has since decreased somewhat from that high, it still represents a much more substantial share of health care than before COVID, this KFF-Epic Research analysis finds.
How Do Prescription Drug Costs in the United States Compare to Other Countries? February 8, 2022 Slideshow
COVID-19 leading cause of death ranking November 10, 2022 Issue Brief This updated analysis examines COVID-19’s effect on mortality rates, and estimates that in January 2022, COVID-19 was number two on the list of leading causes of death in the U.S.
Tracking The Pandemic’s Effects On Health Outcomes, Costs, And Access To Care February 4, 2022 Perspective This Health Affairs Grantwatch article summarizes findings from several KFF-Peterson Health System Tracker analyses with an emphasis on the COVID-19 pandemic’s impact through 2021 and a look ahead toward 2022.
Characteristics of Vaccinated Patients Hospitalized with COVID-19 Breakthrough Infections December 15, 2021 Issue Brief This brief describes the characteristics of fully vaccinated hospitalized patients who have COVID-19 breakthrough infections, in comparison to people who are not fully vaccinated and hospitalized with COVID-19.
When Cost-Sharing Waivers for COVID-19 Treatment Expire for People with Private Insurance Plans August 24, 2020 Slide About 88% – nearly nine in ten – enrollees in the individual and fully-insured group markets are covered by plans that have taken action to limit out-of-pocket costs for patients undergoing treatment for COVID-19 since the start of the pandemic. However, after accounting for waivers that have already expired (20%) or are scheduled to expire by the end of September (16%), just over half of enrollees in these plans will still be eligible for waived cost-sharing in October and beyond.
Cost-Sharing Waivers and Premium Relief by Private Plans in Response to COVID-19 (Nov. 2020 Update) November 20, 2020 Issue Brief An updated issue brief estimates the number of enrollees in individual and fully-insured group market plans that have waived cost-sharing – out-of-pocket costs including coinsurance, copayments, and deductibles – for COVID-19 treatment. The analysis also estimates the number of enrollees whose insurer is offering various forms of premium payment relief.…